why choose us

First received: April 13, 2023

Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19) or Pneumonia

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVI

Brief Summary: A new drug called azeliragon could be used to treat patients with COVID-19 or other pneumonia infections but the researchers don't know.In this study, they are learning the effects of azeliragon patients hospitalized for COVID-19 or pneumonia.

Read more